Cargando…
Genome-wide association study identifies novel loci associated with skin autofluorescence in individuals without diabetes
BACKGROUND: Skin autofluorescence (SAF) is a non-invasive measure reflecting accumulation of advanced glycation endproducts (AGEs) in the skin. Higher SAF levels are associated with an increased risk of developing type 2 diabetes and cardiovascular disease. An earlier genome-wide association study (...
Autores principales: | Vollenbrock, Charlotte E., Roshandel, Delnaz, van der Klauw, Melanie M., Wolffenbuttel, Bruce H. R., Paterson, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764523/ https://www.ncbi.nlm.nih.gov/pubmed/36536295 http://dx.doi.org/10.1186/s12864-022-09062-x |
Ejemplares similares
-
The Association Between Anemia and Skin Autofluorescence, a Marker for Advanced Glycation End Product Accumulation
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2020) -
Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components
por: van Waateringe, Robert P., et al.
Publicado: (2017) -
Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes
por: Boersma, Henderikus E., et al.
Publicado: (2021) -
A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population
por: Boersma, Henderikus E., et al.
Publicado: (2022) -
Lifestyle and clinical determinants of skin autofluorescence in a population‐based cohort study
por: van Waateringe, Robert P., et al.
Publicado: (2016)